Federal contract award
75F40121F19001
DATA RESOURCE FOR POST-MARKETING SURVEILLANCE OF NONMEDICAL USE (NMU) OF PHARMACEUTICALS AND USE OF ILLICIT DRUG SUBSTANCES ? SIX MONTH SURVEILLANCE REPORTS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | B529 — Scientific Data Studies |
| Parent award / vehicle | 75F40121D00032 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.0M |
| Current contract value | $1.0M |
| Potential contract value / ceiling | $1.0M |
| Start date | Sep 24, 2021 |
| Current end date | Dec 29, 2026 |
| Potential end date | Dec 29, 2026 |
| Latest award activity | Jul 6, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 8 of 8 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 6, 2026 | P00007 | $0 | EO 14398 - DATA RESOURCE FOR POST-MARKETING SURVEILLANCE OF NONMEDICAL USE (NMU) OF PHARMACEUTICALS AND USE OF ILLICIT DRUG SUBSTANCES - SIX MONTH SURVEILLANCE REPORTS. NCE |
| Apr 29, 2025 | P00006 | $220.9K | DATA RESOURCE FOR POST-MARKETING SURVEILLANCE OF NONMEDICAL USE (NMU) OF PHARMACEUTICALS AND USE OF ILLICIT DRUG SUBSTANCES - SIX MONTH SURVEILLANCE REPORTS |
| Feb 28, 2024 | P00005 | $207.2K | DATA RESOURCE FOR POST-MARKETING SURVEILLANCE OF NONMEDICAL USE (NMU) OF PHARMACEUTICALS AND USE OF ILLICIT DRUG SUBSTANCES - SIX MONTH SURVEILLANCE REPORTS |
| Aug 2, 2023 | P00004 | $0 | DATA RESOURCE FOR POST-MARKETING SURVEILLANCE OF NONMEDICAL USE (NMU) OF PHARMACEUTICALS AND USE OF ILLICIT DRUG SUBSTANCES - SIX MONTH SURVEILLANCE REPORTS |
| Mar 1, 2023 | P00003 | $195.5K | DATA RESOURCE FOR POST-MARKETING SURVEILLANCE OF NONMEDICAL USE (NMU) OF PHARMACEUTICALS AND USE OF ILLICIT DRUG SUBSTANCES - SIX MONTH SURVEILLANCE REPORTS |
| Aug 13, 2022 | P00002 | $0 | DATA RESOURCE FOR POST-MARKETING SURVEILLANCE OF NONMEDICAL USE (NMU) OF PHARMACEUTICALS AND USE OF ILLICIT DRUG SUBSTANCES - SIX MONTH SURVEILLANCE REPORTS |
| Mar 11, 2022 | P00001 | $184.4K | DATA RESOURCE FOR POST-MARKETING SURVEILLANCE OF NONMEDICAL USE (NMU) OF PHARMACEUTICALS AND USE OF ILLICIT DRUG SUBSTANCES ? SIX MONTH SURVEILLANCE REPORTS |
| Sep 24, 2021 | 0 | $217.0K | DATA RESOURCE FOR POST-MARKETING SURVEILLANCE OF NONMEDICAL USE (NMU) OF PHARMACEUTICALS AND USE OF ILLICIT DRUG SUBSTANCES ? SIX MONTH SURVEILLANCE REPORTS |
Estimated positioning window
Oct 25, 2026 – Jan 23, 2027
85/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 85/100. Available recorded signals: 80 points.
- Contract end 2026-12-29 (65 days from calculation)
- +35 points
- 18 historical awards in this buyer and category group
- +15 points
- 8 recorded award transactions
- +10 points
- Latest award action: 2026-07-06
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.